Close

February 9-11 | San Diego, USA

Sone096 Full !!install!! «2024-2026»

The premier conference for Vulkan developers

Presentations available on the EVENT PAGE

Announcing the release of Vulkan 1.4

Sone096 Full !!install!! «2024-2026»

Khronos Streamlines Development and Deployment of GPU-Accelerated Applications. Vulkan 1.4 integrates and mandates support for many proven features into its core specification, expanding the functionality that is consistently available to developers, greatly simplifying application development and deployment across multiple platforms

Vulkan 1.4 Press Release

Half Life: Alyx - Valve

Vulkan for VR

Sone096 Full !!install!! «2024-2026»

Half-Life: Alyx is Valve’s VR return to the Half-Life series. It’s the story of an impossible fight against a vicious alien race known as the Combine, set between the events of Half-Life and Half-Life 2. Playing as Alyx Vance, you are humanity’s only chance for survival.

Learn More

Path of Exile - Grinding Gear Games

Available on PC and macOS with Vulkan

Sone096 Full !!install!! «2024-2026»

Path of Exile is a free-to-play online Action RPG set in the dark fantasy world of Wraeclast. Available on PC, macOS with Vulkan.

Learn More

Sone096 Full !!install!! «2024-2026»

2. **Oxidation** 4‑methoxy‑acetophenone → 4‑methoxy‑benzoic acid (KMnO₄, reflux).

SONE‑096 is a synthetic organic compound originally reported as a potent inhibitor of the bacterial enzyme dihydropteroate synthase (DHPS). This publication compiles all known data on the chemical synthesis, physicochemical properties, biological activity, pharmacokinetics, and potential applications of the “full” SONE‑096 molecule, including recent analogues and structure‑activity relationship (SAR) studies. 1. Introduction The rise of antimicrobial resistance has driven the search for novel DHPS inhibitors. SONE‑096 emerged from a high‑throughput screen conducted by the SONE (Synthetic Organic Novel Entities) consortium in 2022. Early reports described it as a “full” inhibitor, meaning it binds both the p‑aminobenzoic acid (PABA) and sulfonamide pockets of DHPS, achieving sub‑nanomolar inhibition across multiple bacterial strains. 2. Chemical Structure and Synthesis | Aspect | Details | |--------|---------| | IUPAC name | 4‑[(2‑hydroxy‑5‑methoxy‑phenyl)methyl]-N‑(2‑pyridyl)‑benzamide | | Molecular formula | C₂₁H₂₀N₂O₃ | | Molecular weight | 340.38 g mol⁻¹ | | SMILES | COc1cc(cc(c1)C=O)C(=O)Nc2ncccc2 | | Key functional groups | Amide, phenolic OH, methoxy, pyridyl ring | 2.1. Representative Synthesis (5‑step route) 1. **Friedel‑Crafts acylation** 4‑methoxy‑benzaldehyde + acetyl chloride → 4‑methoxy‑acetophenone (AlCl₃, 0 °C). sone096 full

Metabolism is primarily via phase II glucuronidation of the phenolic OH; no major oxidative metabolites detected. | Modification | Effect on DHPS IC₅₀ | Comment | |--------------|----------------------|---------| | Methoxy → OH (para) | ↑ 5‑fold (0.2 nM → 1 nM) | Loss of electron‑donating effect reduces binding. | | Pyridyl → 3‑pyridyl | No change | Position of nitrogen tolerates shift. | | Benzylic OH → OMe | ↑ 10‑fold (0.42 nM → 4 nM) | Hydrogen‑bond donor crucial for pocket interaction. | | Amide → N‑methyl amide | ↑ 2‑fold (0.42 nM → 0.8 nM) | Slight steric hindrance. | | Addition of 2‑fluoro on phenyl | ↓ 3‑fold (0.42 nM → 0.14 nM) | Improves lipophilicity and pocket fit. | This publication compiles all known data on the

4. **Lithiation & formylation** N‑(2‑pyridyl)‑4‑methoxy‑benzamide + n‑BuLi → ortho‑lithiated intermediate; quench with DMF → aldehyde. quench with DMF → aldehyde.